SNWV Stock — SANUWAVE Health, Inc. Common Stock

SANUWAVE Health, Inc. Common Stock (SNWV)

Updated October 16, 2026.

SNWV is a Stock. Its deepest 1-year drawdown was 88.7%.

SANUWAVE Health, Inc. is a medical device company that develops and commercializes regenerative medicine technologies using noninvasive ultrasound and shockwave treatments to promote tissue repair and regeneration. The company's primary product, the UltraMist system, uses non-thermal ultrasound delivered through a fluid mist to treat acute and chronic wounds in a non-contact, pain-free manner. The company does not currently have a regular distribution history.

SNWV performance

Returns are updating. SNWV's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 88.7%.

SNWV key facts

Asset type

Stock

Asset class

Equity

Inception date

09/30/2009

Distribution frequency

None

Last close

$4.96 (as of 2026-10-16)

Market cap

$42,667,453

Average volume

57543.0

Beta

1.459

Payout ratio

0.0%

P/E ratio

5.9

Forward P/E

18.2482

EPS

$0.84

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SNWV risks and drawbacks

The deepest 1-year drawdown on record here is 88.7%.

Who may consider SNWV — and who may not

It is a weaker fit for investors who need monthly cash flow (SNWV does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on SNWV

• All tickers starting with S

Tagged: Healthcare.

Frequently asked questions